期刊文献+

自身免疫性淋巴细胞增殖综合征1例报告并文献复习 被引量:4

One case report and literature review of autoimmune lymphoproliferative syndrome
原文传递
导出
摘要 目的报道1例自身免疫性淋巴细胞增殖综合征的临床特点、诊断、治疗及随访,提高国内儿科医生对该病的认识。方法 2009年5月中山大学附属第一医院收治1例自身免疫性淋巴细胞增殖综合征患儿,回顾分析该患儿临床资料及诊疗过程,复习国内外相关文献。结果患儿1岁11个月,以全血细胞减少、肝脾淋巴结肿大为主要临床表现,并有肾小球肾炎、炎症性肠病的临床表现,CD3+且CD4、CD8双阴性细胞比例明显升高,伴PaIgG、ANA、ANCA、胰岛素自身抗体等抗体阳性。Fas、FasL及Casp10基因检测未发现基因突变。糖皮质激素联合其他免疫抑制剂治疗短期效果明显,但激素减量时易反复。结论本病例在临床上诊断自身免疫性淋巴增殖综合征可成立。提高对本病的认识可以减少误诊率。 Objective To report the clinical features, its treatment and follow-up of one autoimmune lymphoproliferative syndrome (ALPS), and enhance the recognition of this rare disease in China. Methods The clinical features, treatment and follow-up data of a case diagnosed as ALPS in our hospital were analyzed, and related literature was reviewed. Resuits This 1-year-and- 11- month old boy presented with pancytopenia, hepatosplenomegaly, and lymphadenopathy, as well as the clinical features of glomerulonephritis and inflammatory bowel disease.The percentage of CD3+CD4CD8 double negative T (DNT) cell increased markedly and had positive autoantibodies, such as PAlgG, ANA, ANCA and insulin autnantihody.The genes of Fas, Fas ligand and Caspl0 were sequenced but no mutation was found.Glucocorticosteroid in combination with other immunosuppressive agents was effective in short term, but relapses occurred when glucocorticoste- roid was tapered. Conclusion The diagnosis of autoimmune lymphoproliferative syndrome in this ease is clinically proper. It would reduce misdiagnosis rate if the recognition of this disease is enhanced.
出处 《中国实用儿科杂志》 CSCD 北大核心 2011年第2期121-124,共4页 Chinese Journal of Practical Pediatrics
关键词 自身免疫性 淋巴细胞增殖综合征 肾小球肾炎 炎症性肠病 autoimmune lymphoproliferative syndrome glomcrulonephritis inflammatory bowel disease
  • 相关文献

参考文献3

二级参考文献26

  • 1Bleesing JJ, Brown MR, Straus SE, et al.Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome[J]. Blood, 2001, 98(8):2466-2473.
  • 2Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis[J]. Blood, 2001, 98(1):194-200.
  • 3Oliveira JB, Bleesing J J, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome: report from the 2009 NIH International Workshop[J]. Blood, 2010, Jun 10. [Epub ahead of print].
  • 4Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways [J]. Cell Death and Differentiation, 2003, 10: 124-133.
  • 5Rieux-Laucat F, Blach e re S, Danielan S,et al. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations [J]. Blood, 1999, 94: 2575-2582.
  • 6Le Deist F, Fischer A. Autoimmune lymphoproliferative syndrome. Available online at http://www.orpha.net. 2001, Accessed 3-17-09.
  • 7Raif S G, MD (Cochair), Luigi DN, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee [J]. J Allergy Clin Immunol, 2007, 120 (4): 776-794.
  • 8Christine E J, Roxanne E F, Amy P H, et al. Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance [J]. Am J Hum Genet, 1999, 64: 1002-1014.
  • 9Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model [J]. J Hum Genet, 1998, 43(1): 2-8.
  • 10Bleesing J J, Straus SE, Fleisher TA. Autoimmune lymphoproliferative syndrome, a human disorder of abnormal lymphocyte survival [J]. Pediatr Clin North Am, 2000, 47 (6): 1291-1310.

共引文献3

同被引文献34

  • 1Rao VK, Oliveira JB, How I treat autoimmune lymphoproliferativesyndrome [J]. Blood, 2011, 118(22) : 5741 -5751.
  • 2Price S, Shaw PA, Seitz A, et al. Natural history of autoimmunelymphoproliferative syndrome associated with FAS gene mutations[J]. Blood, 2014,123(13) : 1989 -1999.
  • 3Neven B,Magerus-Chatinet A, Florkin B, et al. A survey of 90patients with autoimmune lymphoproliferative syndrome related toTNFRSF6 mutation [J]. Blood, 2011,118(18) : 4798 -4807.
  • 4Kanegane H, Vilela MM, Wang Y,et al. Autoimmune lympho-proliferative syndrome presenting with glomerulonephritis [ J ] . Pe-diatr Nephrol, 2003,18(5): 454 -456.
  • 5Naumann-Bartsch N,Stachel D,Morhart P, et al. Childhood pol-yarteritis nodosa in autoimmune lymphoproliferative syndrome [ J].Pediatrics? 2010,125(1): el69 - el73.
  • 6Naveed M,Khamis BU , Mannan J. Autoimmune lymphoprolifera-tive syndrome with neonatal onset [ J ]. J Coll Physicians SurgPak, 2014,24(Suppl2) : S124-S126.
  • 7Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnosticcriteria and classification for the autoimmune lymphoproliferativesyndrome ( ALPS) ; report from the 2009 NIH International Work-shop [J]. Blood, 2010,116(14) : e35 -e40.
  • 8Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS-L,IL-10, and double-negative CD4 ' CD8 ' TCR alpha/beta + Tcells are reliable markers of autoimmune lymphoproliferative syn-drome (ALPS) associated with FAS loss of function [J]. Blood,2009,113(13): 3027 -3030.
  • 9Magerus-Chatinet A, Stolzenberg MC, Lanzarotti N, et al. Auto-immune lymphoproliferative syndrome caused by a homozygous nullFAS ligand ( FASLG) mutation [ J]. J Allergy Clin Immunol,2013,131(2) : 486-490.
  • 10Rensing-Ehl A, Janda A, Lorenz MR, et al. Sequential decisionson FAS sequencing guided by biomarkers in patients with lympho-proliferation and autoimmune cytopenia [ J ]. Haematologica,2013,98(12) : 1948 -1955.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部